Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SPONSORED CONTENT: Measuring Physical Activity In Clinical Trials

Executive Summary

ICON's Bill Byrom and Marie McCarthy discuss best practice when choosing, implementing and interpreting data from physical activity monitors in clinical trials.

You may also be interested in...



Clinical Trial Partnerships: Driving Forward New Technologies And Collaborations

Consolidation among contract research organizations (CROs), the emergence of disruptive digital technologies and a continuing emphasis on "patient centricity" and risk-based monitoring (RBM) have featured in the news in the past 12 months.

CRO league tables: Competition, privatization and acquisition

Over the past 12 months, the CRO industry has continued to make its mark in drug development. The IPO of the largest player in the market and the merger of two competitor companies are just two of the brushstrokes that make up the CRO portrait to date. Jo Shorthouse steps back and takes in the view.

Topics

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel